Nita Bhalla

All stories by Nita Bhalla

Investment in social firms could rise to $8 bn by 2025

Investment in social firms could rise to $8 bn by 2025

Rediff.com18 Nov 2016

India has emerged as one of largest destinations in the world for investors keen to put their money into firms doing good. Nita Bhalla reports.

No law broken in funding cluster bomb maker: SBI

No law broken in funding cluster bomb maker: SBI

Rediff.com23 Jun 2016

SBI said it provided credit to Orbital ATK Inc as part of a syndicated deal with other banks.

Varanasi villagers blame Coca-Cola for water scarcity

Varanasi villagers blame Coca-Cola for water scarcity

Rediff.com28 Nov 2015

Central Ground Water Authority declared Arajiline block, where the bottling plant in located, as "over exploited" in 2011

India opens boardrooms to women but few mid-career dropouts return

India opens boardrooms to women but few mid-career dropouts return

Rediff.com19 Nov 2015

Women are opting out of high-flying career due to family responsibilities, says a study.

BSE fines 530 companies for delay in appointing women directors

BSE fines 530 companies for delay in appointing women directors

Rediff.com15 Jul 2015

The Bombay Stock Exchange (BSE) has slapped fines on 530 listed companies for failing to meet a deadline to appoint a women director and boost gender diversity in their boardrooms.

Indian firms mock gender diversity as boardroom deadline passes: Analysts

Indian firms mock gender diversity as boardroom deadline passes: Analysts

Rediff.com1 Apr 2015

US, China and Japan have no quotas for women and have had the lowest increase in female directors.

Economists urge Modi not to restrict rural employment scheme

Economists urge Modi not to restrict rural employment scheme

Rediff.com16 Oct 2014

It has raised rural consumption, created new markets and shored up growth when investment falters.

'Modi must resist US pressure on drug patents'

'Modi must resist US pressure on drug patents'

Rediff.com30 Sep 2014

Western drugmakers, including Pfizer Inc, Novartis AG, Roche Holding AG and Sanofi SA, covet a bigger share of the fast-growing Indian drugs market.